INSP
Inspire Medical Systems, Inc.
Set alert
68.10 USD -3.08 -4.33%
67.80 Day range 71.20
40.05 52-week range 143.99
- YTD
- -26.16%
- 1 year
- -6.80%
- Open
- 70.63
- Prev close
- 71.18
- Mkt cap
- 1.97B
- Vol
- 796.40K
- Avg vol
- 772.91K
- EPS
- 4.54
- P/E
- 15.00
- Div yield
- 0.00%
More statistics
- Low
- 67.80
- High
- 71.20
- Forward P/E
- 44.32
- Beta
- 0.73
- Short ratio
- 4.74
- Inst. own
- 129.28%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 68.45
- 200-d avg
- 58.70
- 1y target
- 68.00
Key statistics
- Market cap
- 1.97B
- Enterprise value
- 1.77B
- Trailing P/E
- 15.00
- Forward P/E
- 44.32
- PEG ratio
- 0.00
- Price / sales
- 2.19
- Price / book
- 2.38
- EPS (TTM)
- 4.54
- Beta
- 0.73
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 15.03%
- Revenue (TTM)
- 898.74M
- Revenue growth
- -7.60%
- Free cash flow
- 94.64M
- Total cash
- 320.68M
- Total debt
- 29.09M
- Return on equity
- 17.97%
- Shares outstanding
- 28.91M
- Short % of float
- 20.34%
- 50-day average
- 68.45
- 200-day average
- 58.70
Analyst view
Consensus: hold
Hold
Price target (mean) 68.00 -0.1% downside
Now 68.10
- Target (low)
- 40.00
- Target (mean)
- 68.00
- Target (high)
- 97.00
Ratings (0m) 18 4 buy · 11 hold · 3 sell
- Strong buy0
- Buy4
- Hold11
- Sell1
- Strong sell2
Next earnings
Nov 2, 2026
Expected Nov 2, 2026. Consensus EPS estimate 0.09087.
Financials — quick view
INSP Revenue — quarterly 200.58M
INSP Net income — quarterly 314.00K
INSP EPS — quarterly 0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2026 | Sep 30, 2026 | 0.08701 | — | — | — |
| Aug 3, 2026 | Jun 30, 2026 | -0.23592 | 0.14 | +0.38 | +159.34% |
| May 4, 2026 | Mar 31, 2026 | -0.27533 | 0.10 | +0.38 | +136.32% |
| Feb 11, 2026 | Dec 31, 2025 | 0.69 | 1.65 | +0.96 | +139.13% |
| Nov 3, 2025 | Sep 30, 2025 | -0.15 | 0.38 | +0.53 | +353.33% |
| Aug 4, 2025 | Jun 30, 2025 | 0.22 | 0.45 | +0.23 | +104.55% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Truist Securities | main | Hold | Hold |
| Oct 7, 2026 | Barclays | init | — | Underweight |
| Oct 2, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Oct 1, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Sep 21, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Sep 11, 2026 | Stifel | main | Buy | Buy |
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- inspiresleep.com
News
- Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78
- Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65
- Inspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes
- RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75
- Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday
- Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97
- Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80
- Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
- Caterpillar, Wayfair, Zebra Technologies, Gartner And Other Big Stocks Moving Higher On Tuesday
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Your note
Sign in to keep a note on INSP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BUCHHOLZ RICHARD | Chief Financial Officer | Sale | Aug 28, 2025 | 50,767 |
| HERBERT TIMOTHY P | Chief Executive Officer | Stock Award(Grant) | Feb 19, 2026 | 163,492 |
| KELLY JASON P | Officer | Sale | Aug 6, 2026 | 18,985 |
| MANN MELISSA | Officer | Stock Award(Grant) | Feb 19, 2026 | 23,609 |
| MCCORMICK SHAWN T | Director | Sale | May 7, 2026 | 30,712 |
| MEAD DANA G JR | Director | Stock Award(Grant) | Apr 29, 2026 | 26,213 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.39% | 4,737,519 | 322.61M | Jun 29, 2026 |
| Wellington Management Group, LLP | 8.24% | 2,382,660 | 162.25M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.23% | 2,088,961 | 142.25M | Jun 29, 2026 |
| Soleus Capital Management, L.P. | 6.68% | 1,931,436 | 131.53M | Jun 29, 2026 |
| AQR Capital Management, LLC | 6.42% | 1,856,800 | 126.44M | Jun 29, 2026 |
| UBS Group AG | 5.69% | 1,645,511 | 112.06M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 7.24% | 2,093,826 | 142.58M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 1,720,772 | 117.18M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.16% | 914,149 | 62.25M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.59% | 750,208 | 51.09M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.28% | 660,263 | 44.96M | Jun 29, 2026 |
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 1.58% | 456,014 | 31.05M | Jun 29, 2026 |